Case report: Disseminated infection by Mycobacterium sherrisii and Histoplasma capsulatum in an African HIV-infected patient

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 5, 2013, Pages 914-917

  Tajań, Juan ^a   Espasa, Mateu ^b   Sala, Montserrat ^a   Navarro, Marta ^a   Font, Bernat ^a   González Mart́in, Julián ^c   Segura, Ferran ^a  

^a CSPT   (Spain)

^b Servicio de Oncología Médica   (Spain)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMIKACIN; AMPHOTERICIN; AZITHROMYCIN; CLARITHROMYCIN; DARUNAVIR; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ETHAMBUTOL; HEAT SHOCK PROTEIN 65; ITRACONAZOLE; LAMIVUDINE; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; RALTEGRAVIR; RIFAMPICIN; RITONAVIR; RNA 16S; STREPTOMYCIN; BACTERIAL PROTEIN; CHAPERONIN 60; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VITRO STUDY; LUNG LAVAGE; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM SHERRISII; MYCOBACTERIUM SHERRISII INFECTION; NUCLEOTIDE SEQUENCE; THORAX RADIOGRAPHY; VIRUS LOAD; AIDS RELATED COMPLEX; CLASSIFICATION; GENETICS; HISTOPLASMA; ISOLATION AND PURIFICATION; MICROBIOLOGY; VIROLOGY;

AJELLOMYCES CAPSULATUS; HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM; MYCOBACTERIUM SHERRISII; MYCOBACTERIUM SIMIAE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL PROTEINS; CHAPERONIN 60; HEAT-SHOCK PROTEINS; HISTOPLASMA; HISTOPLASMOSIS; HIV INFECTIONS; HUMANS; MALE; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; RNA, RIBOSOMAL, 16S;

MLCS; MLOWN;

EID: 84877117548     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0572     Document Type: Article

References (12)

1. Selvarangan R, Wu WK, Nguyen TT, Carlson L, Wallis CK, Stiglich SK, Chen YC, Jost KC Jr, Prentice JL, Wallace RJ Jr, Barrett SL, Cookson BT, Coyle MB, 2004. Characterization of a novel group of mycobacteria and proposal of Mycobacterium sherrisii sp. nov. J Clin Microbiol 42: 52-59. (Pubitemid 38082698)
2. van Ingen J, Tortoli E, Selvarangan R, Coyle MB, Crump JA, Morrissey AB, Dekhuijzen PN, Boeree MJ, van Soolingen D, 2011. Mycobacterium sherrisii sp. nov., a slow-growing non-chromogenic species. Int J Syst Evol Microbiol 61: 1293-1298.
3. Gamperli A, Bosshard PP, Sigrist T, Brandli O, Wildermuth S, Weber R, Mueller NJ, 2005. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient. J Clin Microbiol 43: 4283-4285. (Pubitemid 41129751)
4. Loulergue P, Lamontagne F, Vincent V, Rossier A, Pialoux G, 2007. Mycobacterium sherrisii : a new opportunistic agent in HIV infection? AIDS 21: 893-894. (Pubitemid 46573173)
5. Tortoli E, Galli L, Andebirhan T, Baruzzo S, Chiappini E, de Martino M, Brown-Elliott BA, 2007. The first case of Mycobacterium sherrisii disseminated infection in a child with AIDS. AIDS 21: 1496-1498. (Pubitemid 46988018)
6. Tortoli E, Mariottin A, Mazzarelli G, 2007. Mycobacterium sherrisii isolation from a patient with pulmonary disease. Diagn Microbiol Infect Dis 57: 221-223. (Pubitemid 46135864)
7. Barrera L, Palmero D, Paul R, Lopez B; Grupo de Investigacion de M. simiae, 2010. Disease due to Mycobacterium simiae and "Mycobacterium sherrisii " in Argentina. Medicina (B Aires) 70: 343-346.
8. Ho J, Balm M, Huggan P, Chew N, Venkatachalam I, Archuleta S, 2012. Immune reconstitution inflammatory syndrome associated with disseminated Mycobacterium sherrisii infection. Int J STD AIDS 23: 369-370.
9. Crump JA, van Ingen J, Morrissey AB, Boeree MJ, Mavura DR, Swai B, Thielman NM, Bartlett JA, Grossman H, Maro VP, van Soolingen D, 2009. Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 15: 53-55.
10. Valero G, Moreno F, Graybill J, 1994. Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in a murine model of disseminated infection. Antimicrob Agents Chemother 38: 2676-2677. (Pubitemid 24332609)
11. van Ingen J, Totten SE, Helstrom NK, Heifets LB, Boeree MJ, Daley CL, 2012. In vitro synergy between clofazimine and amikacin in nontuberculous mycobacterial disease. Antimicrob Agents Chemother 56: 5324-6327.
12. van Ingen J, Totten SE, Heifets LB, Boeree MJ, Daley CL, 2012. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int J Antimicrob Agents 39: 173-176.